Category: Top Stories

Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) has entered an eight-year renewable marine fuel supply deal with Repsol SA (OTC:REPYY) at the Port of Barcelona, a first-of-its-kind long-term partnership in the cruise industry.

Eight-Year Fuel Deal Targets Decarbonization

The agreement will support the company’s decarbonization goals by introducing renewable biofuels in 2026 and renewable methanol starting in 2029 across its Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises fleets.

Repsol will supply certified renewable fuels that align with EU sustainability standards and both companies’ commitment to achieving net-zero emissions by 2050.

Read Next: Looking Into Norwegian Cruise Line Holdings Ltd’s Recent Short Interest

The deal directly supports Norwegian’s Sail & Sustain program, which targets a 10% reduction in greenhouse gas intensity by 2026 and 25% by 2030.

Executive Commentary on Cross-Sector Partnership

Harry Sommer, president and CEO of Norwegian Cruise Line Holdings, said the partnership shows how cross-sector cooperation can accelerate sustainability goals.

“Securing long-term access to renewable marine fuels at a key European port aligns directly with our Sail & Sustain program and demonstrates our commitment to advancing towards a more sustainable future,” Sommer said.

Repsol’s Renewable Methanol Production

Repsol will produce renewable methanol at its Ecoplanta facility in Tarragona, Spain, which will convert municipal waste into renewable fuels.

The facility, expected to open in 2029, will process roughly 400,000 tons of waste annually to create about 240,000 tons of renewable fuels and circular products.

Repsol’s renewable fuel network already includes large-scale facilities in Cartagena and Puertollano, Spain, and the company aims to expand its renewable fuel stations in Spain and Portugal to 1,500 by year-end.

Norwegian Cruise Line Holdings said the partnership will help it adopt cleaner energy solutions without requiring major ship modifications, marking a step toward reducing the cruise industry’s environmental footprint.

The announcement follows recent market volatility for Norwegian Cruise Line Holdings, which faced a dip after analysts cited margin pressure and softer pricing trends.

Despite those headwinds, the new partnership underscores the company’s long-term focus on low-carbon solutions and operational efficiency.

Price Action: NCLH shares were trading higher by 1.37% to $23.26 at last check Monday.

Read Next:

• Citigroup, Mastercard, American Airlines Launch New AAdvantage Globe Travel Rewards Card

Photo via Shutterstock

China’s long-struggling economy is showing fresh signs of distress, as exports to the United States collapse under President Donald Trump‘s tariffs and the property market fails to mount a meaningful recovery.

According to United Nations Comtrade data, China shipped $35.88 billion worth of goods to the U.S. in July 2025, a staggering 22% drop from the $45.83 billion exported in the same month last year.

Trump’s Tariffs Bite as China’s Export Machine Slows Down

China’s tech exports have been decimated. Shipments of smartphones to the U.S. plummeted from $2.3 billion in July 2024 to just $534 million this July—a 77% collapse.

Laptop exports fared no better, falling from $3.7 billion to $1.69 billion in the same period.

Even traditionally resilient segments like toys and games saw year-over-year declines. Exports in that category dropped from $3.1 billion to $2.3 billion.

These drops coincide with a spike in tariffs.

Unlike Europe, where a 10% stronger euro played a role in weakening export flows to the U.S., China’s export slump stems almost entirely from tariff impacts.

The Chinese yuan has remained stable against the U.S. dollar, down just 1.5% year-over-year, suggesting minimal currency impact.

As of October 2025, tariffs on Chinese products currently stand at 30%, and President Trump threatened to add a further 100% starting Nov. 1. In 2024, Chinese exporters to the U.S. faced an average tariff rate of just 10.9%.

China’s Economic Growth Falters

The export slump is just one layer of Beijing’s current economic challenge.

China’s gross domestic product grew 4.8% year-over-year in the third quarter, down from 5.2% in the second quarter. That marks the slowest pace of expansion since the third quarter of 2024 and underscores how the country’s recovery has lost momentum despite targeted stimulus and support measures.

The slowdown aligns with market expectations but highlights the strain from multiple economic pressures: shrinking exports, soft household spending, and a seemingly endless real estate crisis.

Consumer spending remains soft despite ongoing efforts by Beijing to stimulate demand. Retail sales rose in September by 3% year-over-year but at the slowest pace in over a year. Unemployment ticked slightly lower but still hovered near a six-month high, weighing on consumer confidence and spending.

China’s property sector, once the backbone of its economy, remains in the red. According to the National Bureau of Statistics, primary home prices across 70 major cities fell 2.7% month-over-month, annualized in September.

The downturn was broad-based across all city tiers. Secondary home prices—tracked by the same agency and third-party platforms—have seen much steeper annual declines, ranging from 5% to as much as 20% depending on the region.

Chinese Tech Stocks Pullback

The fallout from China’s slowing economy, collapsing export machine and the threat of even higher U.S. tariffs is wreaking havoc on Chinese tech stocks.

So far in October, the Invesco China Technology ETF (NYSE:CQQQ) has dropped 8%, pacing for its worst monthly performance since January 2024.

New York-listed shares of Baidu Inc. (NASDAQ:BIDU) are down nearly 9% this month, while Alibaba Group Holding Ltd. (NYSE:BABA) has fallen 7%.

Read Next:

• China’s Rare Earth Policy Could ‘Backfire’, Warn Analysts While Highlighting Options Available To Trump: Beijing ‘May Find Itself Cut Off…’
  

Photo: Shutterstock

WW International, Inc. (NASDAQ:WW), known as WeightWatchers, stock surged Monday after announcing a partnership with Amazon.com, Inc.’s (NASDAQ:AMZN) Amazon Pharmacy to make weight management medications easier to access for its clinic members.

The collaboration offers real-time prescription availability, automatic savings, and home delivery options for patients using weight-loss treatments such as GLP-1 medications.

The initiative comes amid soaring nationwide demand for weight management drugs. Members can now verify in-stock availability, compare delivery times, and choose Amazon Pharmacy to fill their prescriptions, providing faster and more reliable service.

Also Read: Is StubHub About To Turn Big Opportunities Into Bigger Profits?

Amazon Pharmacy Features and Member Benefits

Amazon Pharmacy will automatically apply eligible manufacturer savings at checkout without requiring additional enrollment. Prime members will receive free two-day shipping, while same-day delivery will be available in select areas.

Supported by licensed pharmacists and automated fulfillment technology, the collaboration aims to improve accessibility and simplify the medication process for WeightWatchers Clinic participants.

WeightWatchers Leadership Commentary

“At WeightWatchers, we’re committed to making it simpler and faster to access the weight management medications they need, and our collaboration with Amazon Pharmacy does exactly that,” said Jon Volkmann, Chief Operations Officer at WeightWatchers. “By delivering speed, reliability, and convenience, we’re helping members stay focused on their health goals, not on pharmacy logistics.”

Broader Strategy and Program Results

The partnership aligns with WeightWatchers’ broader strategy to improve medication access, following the launch of its RxFlexFund employer model, which helps businesses expand GLP-1 coverage for employees. By combining medication support with behavioral and nutritional programs, WeightWatchers aims to deliver a comprehensive approach to sustainable weight management.

WeightWatchers said members in its clinical programs have achieved an average 21% body weight reduction after 12 months, exceeding results from many telehealth and clinical trials.

The company said it plans to continue building partnerships that strengthen adherence and improve affordability for patients using prescription weight-loss treatments.

Price Action: WW shares were trading higher by 9.25% to $29.40 at last check Monday.

Read Next:

• IBM Partners With Groq To Bring Lightning-Fast AI To Enterprises Worldwide

Photo by Jonathan Weiss via Shutterstock

IonQ, Inc. (NYSE:IONQ) stock rose on Monday after the company announced its participation as a founding member of Q-Alliance.

Q-Alliance is a new initiative aimed at developing a premier quantum computing hub in Lombardy, Italy.

As a founding member of Q-Alliance, IonQ will bring its expertise in gate-based, universal quantum computing along with its exclusive strengths in quantum networking, security, and sensing.

Also Read: From Tesla And Nvidia To Rigetti And IonQ: Single-Stock ETFs Chase The Next Big Tech Boom

The initiative will develop infrastructure to foster research, innovation, and commercialization of quantum technologies across sectors, including pharmaceuticals, materials science, logistics, and financial services.

Established in support of Italy’s National Strategy for Quantum Technologies, the Q-Alliance unites public and private organizations to advance a cutting-edge quantum innovation ecosystem.

Management Commentary

Niccolo de Masi, Chairman and CEO of IonQ, said, “Through this landmark quantum collaboration, we intend to create quantum applications that can accelerate every segment of Italy’s major industries – from defense to agriculture, automotive to healthcare.”

“All areas of the Italian economy will benefit by leveraging IonQ’s industry-leading quantum computing, quantum networking, and quantum sensing solutions.”

Recent Key Events

Last week, the company’s stock got a boost after it achieved a major step forward in quantum chemistry simulations, demonstrating accurate atomic-level force calculations using its quantum-classical auxiliary-field quantum Monte Carlo (QC-AFQMC) algorithm.

Investors can gain exposure to IONQ via WisdomTree Quantum Computing Fund (BATS:WQTM) and REX AI Equity Premium Income ETF (NASDAQ:AIPI).

Price Action: IONQ shares were trading higher by 4.17% to $65.57 premarket at last check Monday.

Read Next:

• IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?

Image via Shutterstock

Apple Inc.’s (NASDAQ:AAPL) iPhone 17 series outsold the iPhone 16 lineup by 14% in the first 10 days of sales across China and the U.S., Apple’s two largest markets, according to Counterpoint Research’s China and U.S. third-quarter 2025 Smartphone Sell-Out Tracker.

The base iPhone 17 has driven demand in China as consumers responded positively to its strong value proposition, featuring a faster chip, better display, larger storage, and upgraded selfie camera at the same price as the iPhone 16.

The base model has driven strong sales, with overall sell-outs up nearly 33%. In China, consumer demand for the base model has nearly doubled compared to the iPhone 16.

Also Read: Apple iPhone 17 Pro, Pro Max Ship Times Stay Stable Globally: Analyst

In the U.S., the iPhone 17 Pro Max saw the fastest demand surge as major carriers raised device subsidies by 10% to target ultra-premium buyers through long-term financing plans, boosting Apple’s ecosystem loyalty.

Meanwhile, the eSIM-only iPhone Air slightly outperformed the iPhone 16 Plus. Apple opened pre-orders for the Air in China on October 17, a key step for eSIM adoption in the region, though its higher price and shorter pre-order window could limit its initial appeal.

Apple shares climbed on Monday, marking nearly a 7% gain over the past 12 months.

Analyst Commentary

Analysts have highlighted that Apple is gaining momentum from the strong demand for the iPhone 17. However, they felt investors may need to wait until results from the September and December quarters to gauge the full impact.

Gene Munster, managing partner at Deepwater Asset Management, said that the global iPhone’s 17 lead times indicate steady consumer demand. Three weeks after release, average wait times across eight countries were 2.29 weeks — about 13% longer than the iPhone 16’s 2.02 weeks.

Munster expects a slight miss in Apple’s fourth-quarter iPhone sales due to limited contribution from the new model, but anticipates substantial upside in fiscal 2026.

He also projects iPhone revenue to rise over 8% in fiscal 2026, exceeding Wall Street’s 5% consensus. He expects Apple’s guidance for the December quarter to “come in ahead of both the published estimates and the whisper number.”

JPMorgan on Robust Upgrade Cycle

Apple is riding strong demand for its iPhone 17 Series, fueled by loyal users upgrading to premium models and expanding traction in China, according to JPMorgan.

Analyst Samik Chatterjee said JPMorgan’s latest consumer survey points to a robust upgrade cycle led by existing iPhone owners, even as interest from Android users softens compared with last year.

Performance, design, and camera improvements remain the top drivers of upgrades, while AI features ranked lower in purchase motivation, Chatterjee noted.

Price Action: Apple shares were trading higher by 1.81% to $256.85 premarket at last check Monday.

Read Next:

• ASML Q3 Earnings Beat On Strong EUV Demand, AI Boosts Growth

Photo by Azulblue via Shutterstock